S&P Pharma Dose - Episode 34: More Color on PPD’s Rating After IPO | S&P Global Ratings

Name: S&P Pharma Dose - Episode 34: More Color on PPD’s Rating After IPO
Uploaded: 2020-02-11T13:53:34.000Z
Duration: T6M47S
Description: In this episode of S&P Pharma Dose, senior healthcare analyst Ji Liu discusses his view on Pharmaceutical Product Development LLC (PPD) after its recent IPO on Feb. 5, 2020.

In This List

S&P Pharma Dose - Episode 34: More Color on PPD’s Rating After IPO

COMMENTS

U.S. Capital Goods Companies Price In Tariff Costs To Defend Credit

COMMENTS

Global Auto Outlook: From Drive To Dive

COMMENTS

Global Tariff Tracker: Rating Actions As Of May 2, 2025

COMMENTS

Tadawul On The Rise: Saudi Arabia's Investment Plans Fuel Growth

11 Feb, 2020 | 12:00

Listen: S&P Pharma Dose - Episode 34: More Color on PPD’s Rating After IPO

Author Ji Liu
Sector Healthcare & Pharmaceuticals
Tags Americas North America United States of America

In this episode of S&P Pharma Dose, senior healthcare analyst Ji Liu discusses his view on Pharmaceutical Product Development LLC (PPD) after its recent IPO on Feb. 5, 2020.

Author
Ji Liu
Sector
Healthcare & Pharmaceuticals
Tags
Americas North America United States of America

Create a free account to unlock the article.

Gain access to exclusive research, events and more.

Already have an account? Sign in